Cross Country Healthcare, Inc. $CCRN Shares Sold by Acadian Asset Management LLC

Acadian Asset Management LLC trimmed its position in shares of Cross Country Healthcare, Inc. (NASDAQ:CCRN - Free Report) by 82.9% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 86,072 shares of the business services provider's stock after selling 416,145 shares during the period. Acadian Asset Management LLC owned approximately 0.26% of Cross Country Healthcare worth $1,280,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Longfellow Investment Management Co. LLC acquired a new stake in Cross Country Healthcare during the first quarter worth about $59,000. AlphaQuest LLC increased its position in Cross Country Healthcare by 324.6% during the 1st quarter. AlphaQuest LLC now owns 8,297 shares of the business services provider's stock worth $124,000 after purchasing an additional 6,343 shares in the last quarter. Nomura Holdings Inc. acquired a new stake in Cross Country Healthcare during the 1st quarter worth approximately $232,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in shares of Cross Country Healthcare by 4.7% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 18,386 shares of the business services provider's stock worth $334,000 after acquiring an additional 817 shares in the last quarter. Finally, Vident Advisory LLC acquired a new stake in shares of Cross Country Healthcare in the first quarter worth $392,000. 96.03% of the stock is currently owned by institutional investors and hedge funds.

Cross Country Healthcare Trading Up 1.9%

CCRN opened at $13.12 on Thursday. The company has a fifty day simple moving average of $13.18 and a 200 day simple moving average of $13.79. The firm has a market cap of $429.84 million, a price-to-earnings ratio of -50.46, a PEG ratio of 7.69 and a beta of 0.38. Cross Country Healthcare, Inc. has a twelve month low of $9.58 and a twelve month high of $18.33.

Cross Country Healthcare (NASDAQ:CCRN - Get Free Report) last announced its earnings results on Wednesday, August 6th. The business services provider reported ($0.01) earnings per share for the quarter, missing the consensus estimate of $0.07 by ($0.08). The business had revenue of $274.07 million for the quarter, compared to analyst estimates of $292.67 million. Cross Country Healthcare had a negative net margin of 0.70% and a positive return on equity of 1.72%. On average, analysts forecast that Cross Country Healthcare, Inc. will post 0.53 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the stock. Wall Street Zen raised shares of Cross Country Healthcare to a "hold" rating in a research report on Saturday, August 9th. Barrington Research reiterated a "market perform" rating and issued a $18.61 price target on shares of Cross Country Healthcare in a report on Tuesday, June 17th. Six research analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, Cross Country Healthcare presently has a consensus rating of "Hold" and a consensus price target of $17.93.

Cross Country Healthcare Company Profile

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.